Vaccine for Children
The vaccine is the most powerful weapon in the fight against deadly coronavirus. It prevents serious illness, hospitalization, death, and other complications. The CDC reports that 49% of Americans are fully vaccinated. This puts the country closer to ending the pandemic.
The vaccine for children is still a concern. Many young children and adolescents who are eligible for COVID-19 vaccine still have to wait for their turn.
The FDA approved the COVID-19 vaccine earlier for children younger than 12 years old. The FDA has stated that the Pfizer BioNTech COVID-19 vaccine is safe for use in emergency situations. Experts believe that the decision will allow the world to vaccinate teenagers and restore normalcy.
Over the next few months, FDA approval may be granted to more vaccines as covid vaccines for children.
More information about the COVID-19 vaccination for children and adolescents is available here:
- COVID-19 Vaccine For Children
- Vaccine for 12- to 16-Year Old Adolescents
The FDA approved emergency use of the Pfizer BioNTech COVID-19 vaccine in December 2020. The FDA announced at that time that the Pfizer vaccine could also be used as an emergency vaccine in cases involving individuals older than 16 years.
Six months later, FDA approved the use of Pfizer-BioNTech COVID-19 as a COVID vaccine. The FDA stated that the vaccine was available for emergency use authorization (EUA), for children aged 12-15 years old.
After Pfizer had revealed its data, the FDA announced that the vaccine could be used to treat symptomatic coronavirus infections in children aged 12-15 years.
Moderna-NIAID Vaccine For 18-year-olds
FDA has approved the emergency use of Moderna-NIAID vaccine in individuals aged 18 and over.
Recently, the Massachusetts-headquartered pharmaceutical company announced the results of its clinical trial for the vaccine for children (12- to 17-year-olds). Moderna announced that phase 2 and 3 results showed an efficacy rate of 96% for coronavirus symptoms among children aged 12-17 years.
Johnson & Johnson Vaccine For People 18 Years Old and Over
FDA granted permission to the company for an emergency use of the COVID-19 vaccine for those aged 18 and over. Johnson & Johnson grew its vaccine trials for young adults from 12 to 17 years old this year.
Vaccine for children between 2 and 11 years old
Many companies worldwide and in the USA have been trying to make COVID-19 vaccines accessible for people aged 12 and older. How about children between 2 and 11 years of age?
Moderna’s trials for children aged between 2 and 11 years could have similar results to adult studies, according to Dr. Walter Dehority of the University of New Mexico’s department of pediatrics. Dehority is a prominent researcher in Moderna’s vaccine trials and said that it was important to take things slowly for children. The researcher said it was hard to determine the correct dose of COVID vaccine to give to children aged between 2 and 11.
Pfizer-BioNTech may be available by September
According to reports, Pfizer is planning to conduct a pediatric vaccine study on children aged 6-12 years. If all goes well, we might have a COVID vaccine available for children below 12 years old, if everything goes according to plan. Pfizer’s research results will determine the vaccine schedule for children. The sooner the better.
Fall may see Moderna-NIAID available
Moderna, along with Pfizer has been testing COVID vaccines in children under 12 years of age. According to the company it is planning to test its COVID vaccines on children aged 6 to 11. The Moderna-NIAID vaccine could be available for children in fall if its studies prove promising.
Vaccine for Children Between 6 Months and Two Years of Age
Moderna and Pfizer have been working together to test vaccines for children aged 6 months to 11 years. It may take a few more months to vaccinate children below 2.
Pfizer anticipates that the vaccine will be available to children aged 6 months to 2 in the last quarter of 2021.
Moderna is currently testing its pediatric vaccine in children aged 6 months to 2 years. The vaccine could soon be available to children, according to experts. Experts believe that the availability of the vaccine to children between 6 months old and 2 years depends on the results of the study.
Although the world does not yet have a COVID 19 vaccine, particularly for children aged between 6 and 11 years, there are promising signs. If the trials by pharma companies go well, there may be a vaccine for children soon. Protect your children until then. To protect your children from the virus, follow COVID-19 guidelines. Wear a mask and keep social distance.